Genital chronic GVHD in Men after hematopoietic stem cell transplantation: A single-center cross-sectional analysis of 155 patients

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 11, 2013, Pages 1574-1580

  Mueller, Simon M ^a   Haeusermann, Peter ^a   Rovó, Alicia ^a   Halter, Joerg P ^a   Passweg, Jakob ^a   Itin, Peter ^a   Tichelli, André ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Allogeneic HSCT; Late effects; Male genital GVHD

Indexed keywords

CORTICOSTEROID; PIMECROLIMUS;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALOPECIA AREATA; ARTICLE; BALANOPOSTHITIS; BRIEF SEXUAL SYMPTOM CHECKLIST; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CIRCUMCISION; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; ERECTILE DYSFUNCTION; FOLLOW UP; GONORRHEA; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; LICHEN SCLEROSUS ET ATROPHICUS; LOCAL THERAPY; MAJOR CLINICAL STUDY; MALE; MALE GENITAL SYSTEM; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PHIMOSIS; PREMATURE EJACULATION; PSORIASIS VULGARIS; RECIPIENT; SCHOOL CHILD; SEXUAL INTERCOURSE; SEXUALITY; SKIN; WHOLE BODY RADIATION;

ALLOGENEIC HSCT; LATE EFFECTS; MALE GENITAL GVHD;

ADOLESCENT; ADULT; AGED; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; GENITAL DISEASES, MALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PREVALENCE; TRANSPLANTATION CONDITIONING; YOUNG ADULT;

EID: 84885767260     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.07.010     Document Type: Article

References (33)

1. Copelan E.A. Hematopoietic stem-cell transplantation. NEngl J Med 2006, 354:1813-1826.
2. Passweg J.R., Baldomero H., Gratwohl A., et al. The EBMT activity survey: 1990-2010. Bone Marrow Transplant 2012, 47:906-923.
3. Bevans M.F., Mitchell S.A., Barrett A.J., et al. Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: A study protocol. Health Qual Life Outcomes 2011, 9:24.
4. Mayer D.K., Ratichek S., Berhe H., et al. Development of a health-related website for parents of children receiving hematopoietic stem cell transplant: HSCT-CHESS. JCancer Surviv 2010, 4:67-73.
5. Wong F.L., Francisco L., Togawa K., et al. Long-term recovery after hematopoietic cell transplantation: Predictors of quality-of-life concerns. Blood 2010, 115:2508-2519.
6. Spinelli S., Chiodi S., Costantini S., et al. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. Haematologica 2003, 88:1163-1168.
7. Stratton P., Turner M.L., Childs R., et al. Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation. Obstet Gynecol 2007, 110:1041-1049.
8. Zantomio D., Grigg A.P., MacGregor L., et al. Female genital tract graft-versus-host disease: Incidence, risk factors and recommendations for management. Bone Marrow Transplant 2006, 38:567-572.
9. Shanis D., Merideth M., Pulanic T.K., et al. Female long-term survivors after allogeneic hematopoietic stem cell transplantation: Evaluation and management. Semin Hematol 2012, 49:83-93.
10. Hirsch P., Leclerc M., Rybojad M., et al. Female genital chronic graft-versus-host disease: Importance of early diagnosis to avoid severe complications. Transplantation 2012, 93:1265-1269.
11. Riera C., Deroover Y., Marechal M. Severe vaginal chronic graft-versus-host disease (GVHD): Two cases with late onset and literature review. Eur J Gynaecol Oncol 2010, 31:703-704.
12. Flowers M.E., Parker P.M., Johnston L.J., et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: Long-term follow-up of a randomized trial. Blood 2002, 100:415-419.
13. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
14. Au W.Y., Hon C., Lie A.K., et al. Keratoderma blenorrhagica, balanitis and uveitis after HLA-B15 mismatched bone marrow transplantation. Haematologica 2002, 87:ECR10.
15. Au W.Y., Yeung C.K., Cheung M.C., Trendell-Smith N.J. Penile lichen sclerosus after allogeneic stem cell transplantation. Br J Dermatol 2008, 159:470-472.
16. Grigg A.P., Underhill C., Russell J., Sale G. Peyronie's disease as a complication of chronic graft versus host disease. Hematology 2002, 7:165-168.
17. Kami M., Kanda Y., Sasaki M., et al. Phimosis as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998, 21:721-723.
18. Nylander E., Wahlin Y.B., Lundskog B., Wahlin A. Genital graft-versus-host disease in a male following allogeneic stem cell transplantation. Acta Derm Venereol 2007, 87:367-368.
19. Patel S.T., Woodward M.N., Williams M., et al. Graft-versus-host disease and phimosis. JPediatr Urol 2008, 4:165-166.
20. Yared J., Gojo I., Akpek G. Glans penis involvement: An under-recognized manifestation of chronic GVHD. Bone Marrow Transplant 2012, 47:1006-1007.
21. Rosen R.C., Cappelleri J.C., Smith M.D., et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999, 11:319-326.
22. Hatzichristou D., Rosen R.C., Broderick G., et al. Clinical evaluation and management strategy for sexual dysfunction in men and women. JSex Med 2004, 1:49-57.
23. Lehmann K. The evaluation of erectile dysfunction. Ther Umsch 2010, 67:117-121.
24. Dignan F.L., Scarisbrick J.J., Cornish J., et al. Organ-specific management and supportive care in chronic graft-versus-host disease. Br J Haematol 2012, 158:62-78.
25. Rizzo J.D., Curtis R.E., Socie G., et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood 2009, 113:1175-1183.
26. Barbagli G., Palminteri E., Mirri F., et al. Penile carcinoma in patients with genital lichen sclerosus: a multicenter survey. JUrol 2006, 175:1359-1363.
27. Clouston D., Hall A., Lawrentschuk N. Penile lichen sclerosus (balanitis xerotica obliterans). BJU Int 2011, 108(Suppl. 2):14-19.
28. Micali G., Nasca M.R., Innocenzi D. Lichen sclerosus of the glans is significantly associated with penile carcinoma. Sex Transm Infect 2001, 77:226.
29. Nasca M.R., Innocenzi D., Micali G. Penile cancer among patients with genital lichen sclerosus. JAm Acad Dermatol 1999, 41:911-914.
30. Nasca M.R., Panetta C., Micali G., Innocenzi D. Microinvasive squamous cell carcinoma arising on lichen sclerosus of the penis. JEur Acad Dermatol Venereol 2003, 17:337-339.
31. Fleischer A.B. Black box warning for topical calcineurin inhibitors and the death of common sense. Dermatol Online J 2006, 12:2.
32. Patel T.S., Greer S.C., Skinner R.B. Cancer concerns with topical immunomodulators in atopic dermatitis: Overview of data and recommendations to clinicians. Am J Clin Dermatol 2007, 8:189-194.
33. Ring J., Mohrenschlager M., Henkel V. The US FDA "black box" warning for topical calcineurin inhibitors: An ongoing controversy. Drug Saf 2008, 31:185-198.